Neuro diseases Flashcards
Define Neurodegeneration and Neurodegenerative disease
- Neurodegeneration = neuro (relating to neurons) + degeneration (progressive loss)
- Neurodegenerative disease = any disease caused by neurodegeneration
What do neuro diseases affect?
When do they begin?
• Affect the CNS or PNS (or both)
- Begin at any stage of life
- The most common ones are associated with ageing
- Rarer types of neurodegenerative disease start in childhood or even from birth
- Earlier age of onset = greater genetic contribution
- Later age of onset = more likely a sporadic (or idiopathic) disease
Have a look at some examples
On table
Are Neurodegenerative diseases heterogenous and why?
• Neurodegenerative diseases are highly heterogeneous (varied in presentation), the reasons for this are:
o Some disease names are really umbrella terms
Conditions with overlapping phenotypes, but distinct causes (e.g. at least 25 types of SCA from mutations in different genes)
o Some diseases are inherently pleiotropic
Symptoms manifest differently in different people
(e.g. Parkinson’s disease symptoms unique to individual)
What are the patterns of these diseases?
- Molecular impairment somewhere in the cell
- Decreased transmission at synapse
- “Dying back” of neurites (axons and/or dendrites)
- Cell death
What is the distance between axon terminal and nucleus
a neuron’s “Achilles heel”
What are the common features of these diseases?
- Protein aggregation (“proteinopathies”)
- Lysosomal dysfunction
- Mitochondrial dysfunction
- Associated inflammation via activation of glia
What are the clinical and research problems?
• Neurodegenerative diseases rarely manifest overt signs and symptoms until long after neurodegeneration has begun
o Early treatment is impossible without early diagnosis
o Therapeutic challenge is considerable
• For CNS disorders, studies of affected tissue is very difficult until death
o Advanced brain pathology is of little help to understanding the causes
• Neurodegenerative diseases remain incurable
What is dementia?
- A decline in memory and other cognitive functions that impair quality of life
- Impairments in dementia are distinct from “normal” cognitive lapses, e.g.
Normal ageing = gradual decline in normal cognition, gradual changes in personality
What are the PATHOLOGICAL HALLMARKS of Alzheimers?
On images
Proteinopathies • Amyloid plaques • Extracellular protein aggregates • Enriched in Aβ peptides Neurofibrillary tangles • Also called paired helical filaments • Intracellular protein aggregates • Enriched in Tau protein
What causes alzheimers disease?
Aβ peptide is cleaved from a transmembrane protein called amyloid beta precursor protein (APP) by proteases
Mutations to three proteins involved in Aβ peptide processing are known to cause rare early onset forms of Alzheimer’s
• APP
• PSEN1 - Presenilin-1 and Presenilin-2; both a components of γ-secretase
• PSEN2 - Presenilin-1 and Presenilin-2; both a components of γ-secretase
What is tau and how does it cause alzheimers?
- Tau normally binds microtubules in axons
- Hyperphosphorylated tau is displaced causing:
Tangles
Destabilised microtubules
In typical late onset AD (i.e. not genetic forms of AD), neurofibrillary tangles are:
• Seen before amyloid plaques
• Well correlated with cell death and progression
Suggests Tau is upstream Aβ = Tau hypothesis
What are the 3 roles of microtubules in neurites?
- Structure/shape of cell
- Positioning of organelles
- Motorways for transporting
vesicular cargo
TAU OR AMYLOID?
• Still really controversial!
• Probably more evidence for amyloid, but…
o Therapies based on inhibiting Aβ aggregation so far haven’t worked
• Tangles and plaques may be red herrings
o Are they pathogenic or by-standers? Or even protective?
o Oligomeric forms of Aβ and tau are more likely to be pathogenic
• Could both be downstream of other factors?
What are the other risk factors of AD?
- Down syndrome (APP is on chromosome 21)
- Gender (more common in women)
- High BP, Cardiovascular disease, Diabetes
- Low education
- Head injury
- Smoking and drinking
- Only a small genetic risk contribution for late-onset AD (APOE gene status most significant)